GERN
Geron Corp
Price:  
3.66 
USD
Volume:  
5,825,272.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN EV/EBITDA

-239.5%
Upside

As of 2024-05-23, the EV/EBITDA ratio of Geron Corp (GERN) is -9.74. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GERN's latest enterprise value is 2,041.07 mil USD. GERN's TTM EBITDA according to its financial statements is -209.66 mil USD. Dividing these 2 quantities gives us the above GERN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.3x - 17.3x 11.7x
Forward P/E multiples 12.9x - 20.9x 17.9x
Fair Price (4.44) - (6.00) (5.10)
Upside -221.3% - -263.9% -239.5%
3.66 USD
Stock Price
(5.10) USD
Fair Price

GERN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-22 -9.74
2024-05-21 -9.85
2024-05-20 -9.93
2024-05-17 -10.16
2024-05-16 -10.41
2024-05-15 -10.41
2024-05-14 -9.79
2024-05-13 -9.96
2024-05-10 -10.13
2024-05-09 -10.35
2024-05-08 -10.16
2024-05-07 -10.32
2024-05-06 -9.93
2024-05-03 -10.49
2024-05-02 -10.55
2024-05-01 -10.91
2024-04-30 -10.49
2024-04-29 -11.08
2024-04-26 -10.10
2024-04-25 -9.46
2024-04-24 -9.51
2024-04-23 -9.29
2024-04-22 -9.93
2024-04-19 -9.82
2024-04-18 -9.93
2024-04-17 -9.79
2024-04-16 -9.51
2024-04-15 -9.15
2024-04-12 -9.68
2024-04-11 -10.04
2024-04-10 -9.12
2024-04-09 -9.09
2024-04-08 -8.81
2024-04-05 -8.78
2024-04-04 -8.48
2024-04-03 -8.48
2024-04-02 -8.17
2024-04-01 -8.36
2024-03-28 -8.73
2024-03-27 -8.76
2024-03-26 -8.73
2024-03-25 -8.62
2024-03-22 -8.76
2024-03-21 -8.81
2024-03-20 -9.12
2024-03-19 -8.62
2024-03-18 -8.38
2024-03-15 -8.90
2024-03-13 -4.39
2024-03-12 -4.75